Rob Ruijtenbeek

Rob Ruijtenbeek, PhD, currently serves as Vice President and Head of Antibody Discovery Technologies at Genmab since August 2018, having previously held the positions of Senior Director and Director in Antibody Technologies. Prior to Genmab, Rob was with PamGene from 2001 to August 2018, where roles included Vice President of Research & Development and Vice President of Biological Sciences, contributing to the management team and overseeing scientific research and development. Academic credentials include a PhD in Medicinal Chemistry and Immunology from Utrecht University, where Rob conducted doctoral studies from 1996 to 2001, and a Master's degree in Chemistry from Radboud University, completed in 1996.